Cargando…
Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells
SGLT2 inhibitor-related nephroprotection is—at least partially—mediated by anti-inflammatory drug effects, as previously demonstrated in diabetic animal and human studies, as well as hyperglycemic cell culture models. We recently presented first evidence for anti-inflammatory potential of empagliflo...
Autores principales: | Pirklbauer, Markus, Sallaberger, Sebastian, Staudinger, Petra, Corazza, Ulrike, Leierer, Johannes, Mayer, Gert, Schramek, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151056/ https://www.ncbi.nlm.nih.gov/pubmed/34064989 http://dx.doi.org/10.3390/ijms22105089 |
Ejemplares similares
-
Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells
por: Pirklbauer, Markus, et al.
Publicado: (2020) -
Synergistic induction of CCL2/MCP-1 expression driven by oncostatin M and IL-1β in human proximal tubular cells depends on STAT3 and p65 NFκB/RelA
por: Sarközi, Rita, et al.
Publicado: (2015) -
Anti-inflammatory potential of Empagliflozin
por: Pirklbauer, Markus
Publicado: (2021) -
Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS)
por: Sallaberger, Sebastian, et al.
Publicado: (2022) -
Exosomal mitochondrial tRNAs and miRNAs as potential predictors of inflammation in renal proximal tubular epithelial cells
por: Ranches, Glory, et al.
Publicado: (2022)